2 results
Not approvedWill not start
To evaluate health related QoL under an oral cyclic treatment with physiological steroid hormones: Duogestan®.
Approved WMOCompleted
The purpose of the multicenter, randomized, open-label, parallel-group study EFC11628 is to compare the efficacy and safety of HOE901-U300 with that of Lantus®, both given once-daily s.c. as part of a basal-bolus insulin regimen in patients with…